Interstitial vascularity in fibrosing alveolitis

American Journal of Respiratory and Critical Care Medicine

Volumn 167, Issue 3, 2003, Pages 438-443

  Renzoni, Elisabetta A ^a   Walsh, David A ^b   Salmon, Michael ^b   Wells, Athol U ^b   Sestini, Piersante ^b   Nicholson, Andrew G ^b   Veeraraghavan, Srihari ^b   Bishop, Anne E ^b   Romanska, Hanna M ^b   Pantelidis, Panagiotis ^b   Black, Carol M ^b   Du Bois, Roland M ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Endothelial proliferation; Pathologic neovascularization; Pulmonary fibrosis; Scleroderma

Indexed keywords

CYCLINE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COMPUTER ANALYSIS; ENDOTHELIUM CELL; FEMALE; FIBROSING ALVEOLITIS; GAS EXCHANGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OPEN LUNG BIOPSY; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; VASCULARIZATION;

ADULT; AGED; BIOPSY; BLOOD GAS ANALYSIS; ENDOTHELIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROLIFERATING CELL NUCLEAR ANTIGEN; PULMONARY ALVEOLI; PULMONARY FIBROSIS;

EID: 0037321858     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200202-135OC     Document Type: Article

References (26)

1. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517-525.
2. Turner-Warwick M. Precapillary systemic-pulmonary anastomoses. Thorax 1963;18:225-237.
3. Peao MND, Aguas AP, DeSa CM, Grande NR. Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin. Anat Rec 1994;238:57-67.
4. Keane MP, Arenberg DA, Lynch JP, Whyte RY, Iannettoni MD, Burdick MD, Wilke CA, Morris SB, Glass MC, DiGiovine B, et al. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997;159:1437-1443.
5. Keane MP, Belperio JA, Moore TA, Moore BB, Arenberg DA, Smith RE, Burdick MD, Kunkel SL, Strieter RM. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol 1999;163:5686-5692.
6. Maricq HR. Comparison of quantitative and semiquantitative estimates of nailfold capillary abnormalities in scleroderma spectrum disorders. Microvasc Res 1986;32:271-276.
7. Black CM, du Bois R. Organ involvement: pulmonary. In: Clements PJ, Furst DE, editors. Systemic sclerosis. Baltimore, MD: Williams and Wilkins; 1996. p. 299-331.
8. Wells AU, Cullinan P, Hansell DM, Rubens MB, Black CM, Newman-Taylor AJ, Du Bois RM. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1994;149:1583-1590.
9. Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002;165:1581-1586.
10. Wells AU, Hansell DM, Haslam PL, Rubens MB, Cailes J, Black CM, du Bois RM. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis. Am J Respir Crit Care Med 1998;157:1474-1482.
11. Chan TY, Hansell DM, Rubens MB, du Bois RM, Wells AU. Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans. Thorax 1997;52:265-270.
12. Wells AU, Hansell DM, Rubens MB, Cailes JB, Black CM, du Bois RM. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison. Am J Respir Crit Care Med 1997;155:1657-1664.
13. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This Joint Statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS Board of Directors, June 2001 and by The ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304.
14. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-590.
15. Walsh DA, Wade M, Mapp PI, Blake DR. Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol 1998;152:691-702.
16. Salmon M, Liu YC, Mak JC, Rousell J, Huang TJ, Hisada T, Nicklin PL, Fan Chung K. Contribution of upregulated airway endothelin-1 expression to airway smoothmuscle and epithelial cell DNA synthesis after repeated allergen exposure of sensitized Brown-Norway rats. Am J Respir Cell Mol Biol 2000;23:618-625.
17. Bonassi S, Fontana V, Ceppi M, Barale R, Biggeri A. Analysis of correlated data in human biomonitoring studies: the case of high sister chromatide exchange frequency cells. Mutat Res 1999;438:13-21.
18. Rogers WH. Regression standard errors in clustered samples. Stata Tech Bull 1993;13:19-23.
19. Heath D, Gillund TD, Kay JM, Hawkins CF. Pulmonary vascular disease in honeycomb lung. J Pathol Bacteriol 1968;95:423-430.
20. Cassan SM, Divertie MB, Brown AL. Fine structural morphometry on biopsy specimens of human lung. 2: diffuse idiopathic pulmonary fibrosis. Chest 1974;65:275-278.
21. Lappi-Blanco E, Kaarteenaho-Wiik R, Soini Y, Risteli J, Paakko P. Intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia are highly capillarized. Hum Pathol 1999;30:1192-1196.
22. Kikuchi K, Kubo M, Kadono T, Yazawa N, Ihn H, Tamaki K. Serum concentrations of vascular endothelial growth factor in collagen disease. Br J Dermatol 1998;139:1049-1051.
23. Maricq HR, Harper FE, Khan MM, Tan EM, LeRoy EC. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983;1:195-205.
24. Majewski S, Skopinska-Rozewska E, Jablonska S, Polakowski I, Pawinska M, Marczak M, Szmurlo A. Modulatory effect of sera from scleroderma patients on lymphocyte-induced angiogenesis. Arthritis Rheum 1985;28:1133-1139.
25. Holt CM, Lindsey N, Moult J, Malia RG, Greaves M, Hume A, Rowell NR, Hughes P. Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis. Clin Exp Immunol 1989;78:359-365.
26. Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, Puccetti A. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 2000;6:1183-1186.